CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in CASI Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q1 2024
- Shares held
- 352.2K
- +97.3K (+38.2%) vs. Q1 2024
- Total value
- $1.94M
- +$1.02M (+110.5%) vs. Q1 2024
- New holders
- 7
- 2 more added
- Sold out
- 4
- 5 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $17 |
| Q1 2026 | 1 | $25 |
| Q4 2025 | 16 | $1.06M |
| Q3 2025 | 22 | $4.33M |
| Q2 2025 | 24 | $2.66M |
| Q1 2025 | 23 | $5.93M |
| Q4 2024 | 22 | $7.52M |
| Q3 2024 | 20 | $8.14M |
| Q2 2024 | 23 | $1.94M |
| Q1 2024 | 20 | $920.0K |
| Q4 2023 | 18 | $1.99M |
| Q3 2023 | 19 | $882.6K |
| Q2 2023 | 19 | $1.12M |
| Q1 2023 | 21 | $2.15M |
| Q4 2022 | 1 | $179 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| VR Adviser, LLC | 111,686 | $614.3K | 0.04% | +111,686 | New |
| Wellington Shields Capital Management, LLC | 89,217 | $490.7K | 0.09% | −3,000−3.3% | Reduced |
| Wellington Shields & Co., LLC | 43,091 | $237.0K | 0.08% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 40,800 | $224.4K | 0.00% | +4,000+10.9% | Added |
| Geode Capital Management, LLC | 22,221 | $122.2K | 0.00% | 00.0% | Unchanged |
| Howland Capital Management LLC | 15,072 | $82.9K | 0.00% | −25,357−62.7% | Reduced |
| UBS Group AG | 11,321 | $62.3K | 0.00% | +11,321 | New |
| ADAR1 Capital Management, LLC | 8,240 | $45.3K | 0.01% | +8,240 | New |
| Royal Bank of Canada | 6,900 | $38.0K | 0.00% | +6,900 | New |
| Morgan Stanley | 1,440 | $7.92K | 0.00% | −2,871−66.6% | Reduced |
| Simplex Trading, LLC | 1,042 | $5.00K | 0.00% | +419+67.3% | Added |
| Wells Fargo & Company | 506 | $2.78K | 0.00% | −11,500−95.8% | Reduced |
| BlackRock Inc. | 296 | $1.63K | 0.00% | 00.0% | Unchanged |
| West Paces Advisors Inc. | 100 | $550 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 100 | $550 | 0.00% | +100 | New |
| Bank of America Corp | 53 | $292 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 50 | $276 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 13 | $72 | 0.00% | 00.0% | Unchanged |
| Colonial Trust Co | 11 | $61 | 0.00% | 00.0% | Unchanged |
| Trust Co of Vermont | 10 | $55 | 0.00% | +10 | New |
| Kozak & Associates, Inc. | 10 | $53 | 0.00% | 00.0% | Unchanged |
| Catalyst Funds Management Pty Ltd | 8 | $44 | 0.00% | −1,802−99.6% | Reduced |
| Advisor Group Holdings, Inc. | 8 | $44 | 0.00% | +8 | New |
| FMR LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Mendota Financial Group, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |